Dr. Dispenza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5501 Hopkins Bayview Circle
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224Phone+1 410-550-2300Fax+1 410-550-3256
Summary
- Dr. Dispenza evaluates and treats adults at the Johns Hopkins Asthma & Allergy Center located on the Bayview campus. Her clinical interests include anaphylaxis, hives (urticaria), drug allergy, and food allergy. Her research focuses on IgE-mediated mechanisms of allergies and novel strategies for the diagnosis, prevention, and management of anaphylaxis.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Allergy and Immunology, 2015 - 2018
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2013 - 2015
- Pennsylvania State University College of MedicineClass of 2013, MD, PhD
Certifications & Licensure
- MD State Medical License 2019 - 2026
- IL State Medical License 2016 - 2020
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 118 citationsSystemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients.Melanie C. Dispenza, E. B. Wolpert, Kathryn L. Gilliland, Jenny P. Dai, Zhaoyuan Cong
The Journal of Investigative Dermatology. 2012-09-01 - 56 citationsClassification of hypersensitivity reactions.Melanie C. Dispenza
Allergy and Asthma Proceedings. 2019-11-01 - 27 citationsDiagnosis and novel approaches to the treatment of hypereosinophilic syndromesMelanie C. Dispenza, Bruce S. Bochner
Current Hematologic Malignancy Reports. 2018-06-01
Journal Articles
- Bruton’s Tyrosine Kinase Inhibition Effectively Protects Against Human IgE-Mediated AnaphylaxisMelanie Dispenza, MD, The Journal of Clinical Investigation
Books/Book Chapters
Authored Content
- Bruton’s Tyrosine Kinase Inhibition Effectively Protects Against Human IgE-Mediated AnaphylaxisJune 2020
Press Mentions
- New Pill Could Prevent Anaphylaxis in People with Food, Drug AllergiesJune 2nd, 2020
- Chemotherapy Drug Shows Promise in Treating Everyday AllergiesFebruary 20th, 2018
- Pill That Treats Cancer Prevented Food Allergy Reactions in StudyOctober 24th, 2023
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: